Pavilion Capital and Hansjörg Wyss featured in a series B round for Harvard-founded ReadCoor, whose existing shareholders also include Lilly Asia Ventures.

ReadCoor, a US-based gene sequencing spinout of Harvard University, obtained $27m on Friday in a series B round featuring Singaporean government-owned investment vehicle Pavilion Capital. Investment firm Decheng Capital also participated, as did private investor Hansjörg Wyss, founder of Harvard’s Wyss Institute for Biologically Inspired Engineering, and unnamed existing investors. Founded in 2016, ReadCoor supplies…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.